FDA Advances Drug Development Innovation by Establishing ISTAND as Permanent Qualification Program
Image By: ShaAvhrée Buckman-Garner, M.D., Ph.D., Director of Office of Translational Sciences, Center for Drug Evaluation and Research (CDER), and Mary Thanh Hai, M.D., Acting Director of Office of New Drugs, CDER The U.S. Food and Drug Administration …